2026 Mid-Year Update: What Has Changed in the U.S. Magnesium Market

Two developments are worth a formulator’s attention halfway through 2026: magnesium has widened its lead as one of the most popular supplements in the U.S., and CRN has published an updated evaluation raising its recommended safe intake level for supplemental magnesium. This mid-year update covers what changed, what it does and does not mean, and how it affects sourcing decisions.

Key takeaways

• Magnesium continued climbing in 2026 consumer survey data, widening its lead as the second-most-popular supplement.

• CRN published an updated evaluation raising its recommended safe upper intake level for supplemental magnesium — an industry reference point, not a regulatory change.

• The Daily Value used for labeling remains 420 mg, and FDA labeling rules are unchanged.

• For sourcing, growing demand and a premium, gentleness-led category mean verified quality and reliable supply matter more, not less.

Why a mid-year check-in

Category conditions change faster than sourcing decisions do. We published our overview of demand drivers and category shifts in the U.S. magnesium glycinate market, and two developments since then are worth flagging for brands and formulators planning the second half of the year: continued growth in consumer usage, and an updated industry reference point for safe supplemental intake. Neither changes the fundamentals, but both affect how you plan.

Update 1: magnesium keeps climbing

Independent survey work published in 2026 by ConsumerLab, based on a survey of more than 8,850 regular supplement users, found magnesium continuing its steady climb — up 5.3 percentage points — and widening its lead as the second-most-popular supplement, behind only the year’s fastest riser, creatine.[1] That is consistent with the trajectory in CRN’s consumer survey data, where magnesium rose to roughly one in four supplement users from about one in five the prior year, and ranks among the top five most-used dietary supplements.[2]

The demographic pattern also held: CRN’s data shows magnesium use is especially high among women and older adults — about 27% of female supplement users compared with 19% of males, with usage higher among those aged 55 and over — and consumers commonly cite relaxation and sleep among their reasons for taking it.[2] For brands, that is a stable, well-defined audience, and it is the same pattern we explored in our overview of magnesium glycinate in women’s health formulations.

Update 2: CRN raises its recommended safe intake level

The more technically significant development is that the Council for Responsible Nutrition published an updated safety evaluation raising its recommended upper level for supplemental magnesium intake.[3] Two points of context matter for how you read this.

First, this is an industry association’s scientific reference point, not a regulatory change: it does not alter FDA requirements, does not change what you may claim, and does not by itself authorize any dosing decision. Second, the labeling framework is untouched — the Daily Value used for the percent DV calculation on a Supplement Facts panel remains 420 mg,[4] and elemental magnesium is still what gets declared, as we cover in our guide to elemental magnesium on your Supplement Facts label. Any dosing or claim implications for a specific product should be assessed with qualified regulatory input, within the structure/function framework we describe in marketing magnesium glycinate without overclaiming.

What this means for sourcing in the second half of 2026

Read together, the two updates reinforce a direction rather than change it. A category still growing, still concentrated in relaxation and sleep positioning, and still skewing premium means the sourcing priorities we have argued throughout remain the right ones: verified elemental magnesium, genuine chelation, complete documentation, and reliable supply. If anything, growth raises the cost of getting these wrong, because stockouts and quality drift are more expensive in a rising category. That logic runs through our guides to how to choose a magnesium glycinate supplier and bulk magnesium glycinate pricing.

Two practical implications. For product planning, the premium, gentleness-led end of the category — where magnesium glycinate sits among the forms compared in our magnesium forms compared guide — continues to be where demand concentrates. For qualification, the verification discipline matters more as volumes grow: confirm purity as described in how to tell if magnesium glycinate is pure, and work a structured evaluation as laid out in how to evaluate a new magnesium glycinate supplier.

What has not changed

It is worth being explicit about the constants, because mid-year updates can create a false sense that the ground has shifted. FDA’s labeling framework and the 420 mg Daily Value are unchanged. Structure/function claim rules are unchanged. The chemistry is unchanged — a pure magnesium bisglycinate chelate still tops out around 14% elemental magnesium, as explained in magnesium bisglycinate 14% elemental magnesium, and an elemental figure well above that still suggests an oxide blend, per buffered versus unbuffered magnesium glycinate. Import obligations under FSVP are unchanged. In other words: the market grew, one industry reference point moved, and the fundamentals of sourcing a good material held still.

How MagneINNO fits

A growing, premium-leaning category rewards suppliers that can document what they sell. MagneINNO supplies fully reacted magnesium glycinate and bisglycinate with elemental magnesium verified by ICP-OES (a typical 12.01% on the 12% grade), free magnesium controlled at ≤0.02% w/w, FTIR-based chelation characterization, heavy-metals testing, recognized certifications, and U.S. (California) inventory — detailed on our quality, science, and about pages.

Market conditions do not determine whether a grade fits a specific product; that still depends on your format, positioning, and qualification. The aim of this update is to keep your planning current without overreading a single data point.

What to do next

For the second half of 2026, treat the category as growing but the rules as unchanged: keep labeling to the 420 mg Daily Value and elemental magnesium, keep claims inside the structure/function framework with regulatory input, and let rising volumes raise — not lower — your bar for verified quality and supply reliability. Revisit your supplier qualification if your volumes are scaling.

Planning magnesium sourcing for the rest of 2026?

Tell our team your format, target elemental magnesium, and volumes, and we can share specifications, analytical methods, and documentation, and discuss capacity and U.S. inventory for the second half of the year. Talk to MagneINNO.

Frequently asked questions

Is magnesium still growing in popularity in 2026?

Yes. ConsumerLab’s 2026 survey of more than 8,850 regular supplement users found magnesium up 5.3 percentage points, widening its lead as the second-most-popular supplement, consistent with CRN survey data showing magnesium among the top five most-used supplements at roughly one in four users.

Did CRN change the safe intake level for magnesium?

CRN published an updated evaluation raising its recommended upper level for supplemental magnesium intake. It is an industry association’s scientific reference point, not a regulatory change — it does not alter FDA requirements or authorize any claim, and dosing decisions should be made with qualified regulatory and technical input.

Does this change how I label magnesium?

No. The Daily Value used for the percent DV calculation remains 420 mg, and elemental magnesium is still what is declared on a Supplement Facts panel. FDA labeling requirements and structure/function claim rules are unchanged.

What does this mean for sourcing?

The direction is reinforced rather than changed: a growing, premium-leaning category raises the cost of quality or supply failures, so verified elemental magnesium, genuine chelation, complete documentation, and reliable capacity matter more as volumes scale.

Disclaimer

This article is written for B2B audiences and provides general market information. It is not medical, regulatory, or dosing advice, does not establish permissible finished-product claims, and does not recommend any intake level. Industry reference values are not regulatory limits; labeling, claims, and dosing decisions should be made with qualified regulatory counsel within the applicable FDA framework.

References

[1] ConsumerLab. Survey of supplement popularity, February 2026 (magnesium growth and ranking). https://www.consumerlab.com/news/2026-supplement-popularity-press-release/02-26-2026/

[2] Council for Responsible Nutrition (CRN). Consumer Survey on Dietary Supplements (magnesium usage and demographics). https://www.crnusa.org/newsroom/crn-survey-shows-consistent-supplement-usage-increase-specialty-product-use-over-time

[3] Council for Responsible Nutrition (CRN). Updated evaluation of the safe intake level for supplemental magnesium. https://crnusa.org/newsroom/crns-updated-evaluation-raises-safe-intake-level-magnesium-supplements

[4] U.S. Food and Drug Administration. Daily Value on the Nutrition and Supplement Facts Labels. https://www.fda.gov/food/nutrition-facts-label/daily-value-nutrition-and-supplement-facts-labels

[5] NIH Office of Dietary Supplements. Magnesium — Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/

MagneINNO. Published product information, specifications, and analytical methods. https://www.magneinno.com/